Athira Pharma

-$0.02 (-0.22%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018.

CEO
Mark J. Litton
Employees
35
Headquarters
Bothell, Washington
Founded
2011

ATHA Key Statistics

Market cap
339.10M
Price-Earnings ratio
—
Dividend yield
—
Average volume
319.19K
High today
$9.06
Low today
$8.50
Open price
$8.89
Volume
165.53K
52 Week high
$23.64
52 Week low
$7.56

ATHA Earnings

-$1.12
-$0.75
-$0.37
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.55 per share
Actual
-$0.56 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure